Evidence map›Paper›PMID 35369486›Full record

ArticleFrontiers in microbiology2022

Identification of Bacterial Drug-Resistant Cells by the Convolutional Neural Network in Transmission Electron Microscope Images.

Mitsuko Hayashi-Nishino, Kota Aoki, Akihiro Kishimoto, Yuna Takeuchi, Aiko Fukushima, Kazushi Uchida, Tomio Echigo, Yasushi Yagi, Mika Hirose, Kenji Iwasaki and 4 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mitsuko Hayashi-NishinoSANKEN (Institute of Scientific and Industrial Research), Osaka University, Ibaraki, Japan.
Kota AokiSANKEN (Institute of Scientific and Industrial Research), Osaka University, Ibaraki, Japan.
Akihiro KishimotoSANKEN (Institute of Scientific and Industrial Research), Osaka University, Ibaraki, Japan.
Yuna TakeuchiGraduate School of Pharmaceutical Sciences, Osaka University, Suita, Japan.
Aiko FukushimaSANKEN (Institute of Scientific and Industrial Research), Osaka University, Ibaraki, Japan.
Kazushi UchidaGraduate School of Pharmaceutical Sciences, Osaka University, Suita, Japan.
Tomio EchigoDepartment of Engineering Informatics, Osaka Electro-Communication University, Neyagawa, Japan.
Yasushi YagiSANKEN (Institute of Scientific and Industrial Research), Osaka University, Ibaraki, Japan.
Mika HiroseInstitute for Protein Research, Osaka University, Suita, Japan.
Kenji IwasakiLife Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba, Tsukuba, Japan.
Eitaro Shin'yaSANKEN (Institute of Scientific and Industrial Research), Osaka University, Ibaraki, Japan.
Takashi WashioSANKEN (Institute of Scientific and Industrial Research), Osaka University, Ibaraki, Japan.
Chikara FurusawaRIKEN, Center for Biosystems Dynamics Research, Suita, Japan.
Kunihiko NishinoSANKEN (Institute of Scientific and Industrial Research), Osaka University, Ibaraki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of bacteria that are resistant to antibiotics is common in areas where antibiotics are used widely. The current standard procedure for detecting bacterial drug resistance is based on bacterial growth under antibiotic treatments. Here we describe the morphological changes in enoxacin-resistant

Indexed as

convolutional neural networkdrug resistanceenoxacinEscherichia coliidentificationLPPquinolonetransmission electron microscope

Identifiers

PMID35369486
PMCPMC8965347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.